nach oben

Clinical & Experimental Metastasis

Erschienen in:

01.08.2010 | Research Paper

Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution

verfasst von: Laila Illán Rubio, Bertrand Tavitian, Elina Zueva

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

We compared gene expression patterns related to cancer progression, cell adhesion and cytokine expression in v-Src-transformed isogenic cell lines with different levels of metastatic aggressiveness in syngenic animals: a high (HM) and a low metastatic (LM) cell lines, both predetermined by in vitro oncogenic transformation, and a high metastatic (NM) cell line resulting from in vivo selection of grafted LM cells. While LM and NM shared a common v-Src transforming variant different from that of HM, gene expression patterns were similar in HM and NM but different from that of LM. In this model, the induction of the metastatic phenotype by an oncogene variant or by the host environment led to highly similar expression profiles. If confirmed in other models, these results would be relevant for the diagnosis and treatment of metastasis.

Fidler IJ (1973) Selection of successive tumour lines for metastasis. Nat New Biol 242:148–149PubMed

Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524CrossRefPubMed

Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49–54CrossRefPubMed

Fan C, Oh DS, Wessels L et al (2006) Concordance among gene-expression based predictors for breast cancer. N Engl J Med 355:560–569CrossRefPubMed

Weinberg RA (2008) Mechanisms of malignant progression. Carcinogenesis 6:1092–1095CrossRef

Egan S, Wright J, Jarolin L et al (1987) Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 23:202–205CrossRef

Soker A, Sieweke M (1989) v-src induces clonal sarcomas and rapid metastasis following transduction with a replication-defective retrovirus. Proc Natl Acad Sci USA 86:10123–10127CrossRef

Deichman GI, Kashleva HA, Kluchareva TE, Matveeva VA (1989) Clustering of discrete cell properties essential for tumorigenicity and metastasis II. Studies of Syrian hamster embyo fibroblasts transformed by Rous Sarcoma Virus. Int J Cancer 44:908–910CrossRefPubMed

Tatosyan A, Yatsula B, Shtutman M et al (1996) Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells. Virology 216:347–356CrossRefPubMed

10.

Deichman GI, Gurova KV, Dyakova NA (1994) Accumulation in “normal” lungs of live tumorigenic cells during sub-cutaneous growth of weakly and highly metastasizing tumors and their in vitro sensitivity to growth regulation by normal fibroblasts. Int J Cancer 59:530–537CrossRefPubMed

11.

Deichman GI, Kashkina LM, Mizenina OA et al (1996) Mechanisms of unusually high antioxidant activity of RSV-transformed cells and of its suppression by activated p21^ras. Int J Cancer 66:747–752CrossRefPubMed

12.

Foty RA, Steinberg MS (2004) Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 48:397–409CrossRefPubMed

13.

Kashima T, Nakamura K, Kawaguchi J et al (2003) Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 104:147–154CrossRefPubMed

14.

Poon RT, Chung KK, Cheung ST et al (2004) Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. Clin Cancer Res 10:4150–4157CrossRefPubMed

15.

Secord AA, Darcy KM, Hutson A et al (2007) Gynecologic oncology group study. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol 106:221–232CrossRefPubMed

16.

Maeda K, Nishiguchi Y, Kang SM et al (2001) Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol Rep 8:763–766PubMed

17.

Yamaguchi M, Sugio K, Ondo K, Yano T, Sugimachi K (2002) Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer. Lung Cancer 36:143–150CrossRefPubMed

18.

Takano Y, Kato Y, Masuda M et al (1999) Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol 189:194–200CrossRefPubMed

19.

Hans CP, Weisenburger DD, Greiner TC et al (2005) Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol 18:1377–1384CrossRefPubMed

20.

Schmalbach CE, Chepeha DB, Giordano TJ et al (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:295–302CrossRefPubMed

21.

Roepman P, Wessels LF, Kettelarij N et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37:182–186CrossRefPubMed

22.

Koon N, Schneider-Stock R, Sarlomo-Rikala M et al (2004) Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 53:235–240CrossRefPubMed

23.

Vecchi M, Nuciforo P, Romagnoli S et al (2007) Gene expression analysis of early and advanced gastric cancers. Oncogene 26:4284–4294CrossRefPubMed

24.

Jones JL, Glynn P, Walker RA (1999) Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189:161–168CrossRefPubMed

25.

Mimori K, Ueo H, Shirasaka C, Mori M (2001) Clinical significance of MT1-MMP mRNA expression in breast cancer. Oncol Rep 8:401–403PubMed

26.

Kawanishi H, Matsui Y, Ito M et al (2008) Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res 14:2579–2587CrossRefPubMed

27.

Al-Rawi MA, Rmali K, Watkins G, Mansel RE, Jiang WG et al (2004) Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer 40:494–502CrossRefPubMed

28.

Roato I, Brunetti G, Gorassini E et al (2006) IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One 1:e124CrossRefPubMed

29.

Teruya-Feldstein J, Jaffe ES, Burd PR et al (1999) Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463–2470PubMed

30.

Levina V, Nolen BM, Marrangoni AM et al (2009) Role of eotaxin-1 signaling in ovarian cancer. Clin Cancer Res 15:2647–2656CrossRefPubMed

31.

Thakur A, Bollig A, Wu J, Liao DJ (2008) Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice. Mol Cancer 7:11CrossRefPubMed

32.

Mita K, Zhang Z, Ando Y et al (2007) Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer. Jpn J Clin Oncol 37:575–582CrossRefPubMed

33.

Lu Z, Jiang G, Blume-Jensen P, Hunter T (2001) Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21:4016–4031CrossRefPubMed

34.

Malek RL, Irby RB, Guo QM et al (2002) Identification of Src transformation fingerprint in human colon cancer. Oncogene 21:256–265CrossRef

Titel: Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution
verfasst von: Laila Illán Rubio
Bertrand Tavitian
Elina Zueva
Publikationsdatum: 01.08.2010
Verlag: Springer Netherlands
Erschienen in: Clinical & Experimental Metastasis / Ausgabe 6/2010
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-009-9297-0

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution

Abstract

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Genomics of metastatic progression

Proteomic strategies and challenges in tumor metastasis research

Lung cancer progression and metastasis from the prognostic point of view

Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases

Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie